Experience with TachoSil in obstetric and gynecologic surgery

Area of Science:

• Gynecologic Surgery
• Obstetric Surgery
• Hemostatic Agents

Background:

• Perioperative bleeding is a significant risk in gynecologic and obstetric procedures.
• TachoSil, a hemostatic sealant, offers a potential solution for managing surgical bleeding.
• Evaluating its use in these specific surgical fields is crucial.

Purpose of the Study:

• To assess the feasibility and effectiveness of TachoSil in obstetric and gynecologic surgeries.
• To identify common indications and outcomes associated with TachoSil application.
• To evaluate the traceability of TachoSil usage in clinical practice.

Main Methods:

• Retrospective cohort study at a French university hospital (2007-2009).
• Inclusion of 84 women experiencing perioperative bleeding requiring TachoSil.
• Data collection included patient demographics, surgical details, transfusion needs, and postoperative course.

Main Results:

• TachoSil was utilized in 84 women, with indications including ovarian malignancy, fibroma, and breast cancer.
• Application sites included uterine serosa (n=16) and major vascular axis (n=7).
• 24 women received blood transfusions, and 3 required repeat surgery; TachoSil use was unrecorded in 51% of cases.

Conclusions:

• TachoSil demonstrates effectiveness and good tolerability in obstetric and gynecologic surgeries.
• The study highlights the need for enhanced measures to improve the traceability of TachoSil application.
• Further research into standardized documentation practices for hemostatic agents is warranted.